ADVERTISEMENT
 |
|
|
Top Stories
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
/ read more /
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
/ read more /
|
|
SubscribeSubscribers can enjoy each full issue of BioPharm International in print, or via BioPharm apps.
subscription offers
|
|
|
INTERPHEX 2018 Keynote Series
Blockchain and Serialization
Experts will discuss information technology including the internet of things, blockchain technology, and serialization.
Learn more |
|
ADVERTISEMENT
 |
|
|
Industry News
National Institutes of Health researchers use genomics to show that squamous cell carcinomas differ from other cancers, which could advance treatments for head and neck and other cancers.
/ read more /
A new study by the Business Research Company reveals prominent contract research organization outsourcing trends.
/ read more /
More Industry News
|
|
|
|
Biopharma News
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
/ read more /
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
/ read more /
More Biopharma News
|
|
|
Supplier News
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
/ read more /
ReForm Biologics and KBI Biopharma will collaborate to improve biopharmaceutical formulations and development.
/ read more /
More Supplier News
|
|
|
Regulatory News
FDA sent a warning letter to Tris Pharma Inc. after investigators found the company had failed to properly investigate batch failures and establish quality control procedures.
/ read more /
|
|
|
The agency has assigned new EU member state rapporteurs and co-rapporteurs to medicines previously assigned to the UK’s Medicines and Healthcare products Regulatory Agency.
/ read more /
More Regulatory News
|
|
|
|
ADVERTISEMENT
BIO International Convention
BIO International Convention is back in Boston, June 4-7, to celebrate history-making innovation. This is the only event where you can access the global biotech and pharma community via Partnering, attend 150 education sessions and network with 16,000+ attendees from 74 countries. Discover the next generation of cutting-edge products, therapies, and cures at events all week long at BIO 2018. Learn more at
 convention.bio.org.
|
|
|
|
FEATURED TOPICS
|
|
SUPPLY CHAIN/LOGISTICS
Certificates of analysis can be used to monitor the reliability of products and their suppliers, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
/ read more /
|
|
|
|
|
ANALYSIS
Access to multiple analytical techniques is essential for fully characterizing complex protein formulations.
/ read more /
|
|
|
|
|
|
OUTSOURCING
Outsourcing analytics can be a cost-effective way for biopharma companies to adapt to new technologies and regulations.
/ read more /
|
|
|
NEW PRODUCTS AND SERVICES
 |
With Hamilton’s family of Arc intelligent sensors, transcription errors are no longer a concern for daily operations of process sensors.
/ Learn more / |
 |
Tosoh Bioscience offers a comprehensive line of products including TSKgel® and TOYOPEARL® bulk media, process development products, TSKgel U/HPLC columns, as well as a unique EcoSEC® GPC System for polymer characterization.
/ Learn more / |
 |
WuXi Biologics offers a comprehensive, integrated, and customizable platform for biologics development.
/ Learn more / |
|
|
|
Events
April 24–26, 2018
April 25–27, 2018
June 4–7, 2018
more events
|
|
|
eBook
|
How are contract development and manufacturing contract service organizations meeting the development and manufacturing needs of innovator biopharmaceuticals and biosimilars companies? In this BioPharm International ebook, the editors examine trends, partnerships, manufacturing capacity, regulatory, supply chain, and technical expertise issues.
|
|
|
|
|
|
